Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis.
Kanai D, Wakui H, Hanaoka M, Haze T, Azushima K, Shinoda S, Tsukamoto S, Taguchi S, Kinguchi S, Kanaoka T, Toya Y, Hirawa N, Kato H, Watanabe F, Hanaoka K, Mitsuhashi H, Yamaguchi S, Ohnishi T, Tamura K. Kanai D, et al. Among authors: azushima k. Clin Exp Nephrol. 2023 Jul;27(7):639-647. doi: 10.1007/s10157-023-02342-0. Epub 2023 Mar 28. Clin Exp Nephrol. 2023. PMID: 36977892 Free PMC article.
Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis.
Ishigami T, Nanki T, Sugawara T, Uchida K, Takeda H, Sawasaki T, Chen L, Doi H, Arakawa K, Saigo S, Yoshimi R, Taguri M, Kimura K, Hibi K, Wakui H, Azushima K, Tamura K, On Behalf Of Oracle Arthritis Investigators. Ishigami T, et al. Among authors: azushima k. Methods Protoc. 2021 Nov 15;4(4):83. doi: 10.3390/mps4040083. Methods Protoc. 2021. PMID: 34842780 Free PMC article.
Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients.
Kawai Y, Toya Y, Wakui H, Fujikawa T, Ueda E, Azushima K, Kinguchi S, Mitsuhashi H, Kawano T, Kuji T, Yamaguchi S, Ohnishi T, Tamura K. Kawai Y, et al. Among authors: azushima k. J Pharmacol Sci. 2021 Sep;147(1):118-125. doi: 10.1016/j.jphs.2021.05.010. Epub 2021 Jun 12. J Pharmacol Sci. 2021. PMID: 34294362 Free article.
Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: a multicenter, randomized, parallel-group controlled trial (ATH-D-14-01021.R2).
Azushima K, Tamura K, Haku S, Wakui H, Kanaoka T, Ohsawa M, Uneda K, Kobayashi R, Ohki K, Dejima T, Maeda A, Hashimoto T, Oshikawa J, Kobayashi Y, Nomura K, Azushima C, Takeshita Y, Fujino R, Uchida K, Shibuya K, Ando D, Tokita Y, Fujikawa T, Toya Y, Umemura S. Azushima K, et al. Among authors: azushima c. Atherosclerosis. 2015 May;240(1):297-304. doi: 10.1016/j.atherosclerosis.2015.01.025. Epub 2015 Mar 25. Atherosclerosis. 2015. PMID: 25818388 Free article. Clinical Trial.
Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension.
Ohsawa M, Tamura K, Wakui H, Maeda A, Dejima T, Kanaoka T, Azushima K, Uneda K, Tsurumi-Ikeya Y, Kobayashi R, Matsuda M, Uchida S, Toya Y, Kobori H, Nishiyama A, Yamashita A, Ishikawa Y, Umemura S. Ohsawa M, et al. Among authors: azushima k. Kidney Int. 2014 Sep;86(3):570-81. doi: 10.1038/ki.2014.95. Epub 2014 Apr 2. Kidney Int. 2014. PMID: 24694992 Free PMC article.
An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
Kobayashi R, Wakui H, Azushima K, Uneda K, Haku S, Ohki K, Haruhara K, Kinguchi S, Matsuda M, Ohsawa M, Toya Y, Nishiyama A, Yamashita A, Tanabe K, Maeshima Y, Umemura S, Tamura K. Kobayashi R, et al. Among authors: azushima k. Kidney Int. 2017 May;91(5):1115-1125. doi: 10.1016/j.kint.2016.10.035. Epub 2017 Jan 10. Kidney Int. 2017. PMID: 28081856 Free article.
Modelling diabetic nephropathy in mice.
Azushima K, Gurley SB, Coffman TM. Azushima K, et al. Nat Rev Nephrol. 2018 Jan;14(1):48-56. doi: 10.1038/nrneph.2017.142. Epub 2017 Oct 24. Nat Rev Nephrol. 2018. PMID: 29062142 Review.
Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue.
Ohki K, Wakui H, Kishio N, Azushima K, Uneda K, Haku S, Kobayashi R, Haruhara K, Kinguchi S, Yamaji T, Yamada T, Minegishi S, Ishigami T, Toya Y, Yamashita A, Imajo K, Nakajima A, Kato I, Ohashi K, Tamura K. Ohki K, et al. Among authors: azushima k. Sci Rep. 2018 Feb 12;8(1):2846. doi: 10.1038/s41598-018-21270-8. Sci Rep. 2018. PMID: 29434287 Free PMC article.
98 results